Emrullah Yilmaz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Emrullah Yilmaz
Jun 25, 2024, 16:15 |
Career
Emrullah Yilmaz: Excited to join the amivantamab clinical team at Johnson and Johnson Innovative Medicine
Emrullah Yilmaz, Medical Director at Johnson & Johnson Innovative Medicine, shared on LinkedIn: "I’m happy…
Oct 22, 2023, 16:53 |
Blog
Emrullah Yilmaz: Thank you, ACS CAN, for organising the Ohio Policy Forum at the Statehouse
Emrullah Yilmaz, Director of Precision Oncology at Cleveland Clinic, shared on LinkedIn: “Thank you American…
Aug 25, 2023, 18:30 |
Career
Emrullah Yilmaz: I’m happy to share that I’m starting a new position as Director of Precision Oncology at Cleveland Clinic!
Quoting Emrullah Yilmaz, the Director of Precision Oncology at Cleveland Clinic, on LinkedIn: "I’m happy…
All:
3
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube